SCHEMBL24475433

SCHEMBL24475433

c1ccc2cc(-c3ccc4cc(-c5ccc6ccc(-c7cccc8cccnc78)nc6c5)ccc4n3)ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.44
RAB9A P51151 6/20 0.44
POLB P06746 1/20 0.44
KDM4E B2RXH2 5/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
NFKB1 P19838 3/20 0.39
CYP3A4 P08684 3/20 0.39
MAPT P10636 3/20 0.39
CYP2D6 P10635 2/20 0.39
LMNA P02545 2/20 0.39
GMNN O75496 2/20 0.39
TP53 P04637 2/20 0.39
THPO P40225 2/20 0.39
PMP22 Q01453 2/20 0.39
HSP90AA1 P07900 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
MMP8 P22894 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24475653 0.96 SMN1; SMN2 (0.42) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL23016242 0.96 NPC1 (0.47) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL24454115 0.96 SMN1; SMN2 (0.42) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL24475564 0.95 NPC1 (0.44) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL22281853 0.93 TOP1 (0.47) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL22282027 0.92 NPC1 (0.43) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL24475561 0.91 NPC1 (0.45) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL23016223 0.91 NPC1 (0.47) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL24475574 0.91 CCR1 (0.42) NPC1RAB9APOLBKDM4ESMN1; SMN2
SCHEMBL24454182 0.91 CCR1 (0.42) NPC1RAB9APOLBKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE LT MATERIALS CO., LTD. (KR) 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220173329-A1 COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OXER1, OCIAD1, OR10J3 NPC1 953/4885RAB9A 2499/4885POLB 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.